Amphastar Pharmaceuticals Inc expected to post earnings of 41  cents a share - Earnings Preview

Amphastar Pharmaceuticals,

25/02/2023 03:08

* Amphastar Pharmaceuticals Inc  AMPH.OQ   AMPH.O  is
expected
to show a rise in quarterly revenue when it reports  results on
February 28. 
    * The Rancho Cucamonga California-based  company is expected
to
report  a 5.0% increase in revenue to $126.977 million from
$120.89 million a year ago, according to the mean estimate from
4 analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Amphastar
Pharmaceuticals
Inc is for earnings of 41 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $37​, above​ its last closing price
of $32.54. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  0.40        0.39       0.38      Missed  -3.6
 Jun. 30 2022  0.35        0.35       0.39      Beat    12.1
 Mar. 31 2022  0.36        0.36       0.47      Beat    30.6​
 Dec. 31 2021  0.33        0.36       0.42      Beat    16.1
 ​​Sep.        0.25        0.24       0.46      Beat    89
 30 2021                                                
 Jun. 30 2021  0.22        0.21       0.21      Met     0.8​
 Mar. 31 2021  0.18        0.18       0.27      Beat    46.5
 Dec. 31 2020              0.14       0.16      Beat    16.7
 This summary was machine generated February 25 at 03:08 GMT. 
All figures in US dollars  unless otherwise stated